KACI RITCHEY: Open Payments
NPI 1952705824 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 38 payments from 11 companies in 2025. Trend: 2023 $549 · 2024 $722 · 2025 $711
Food & beverage: $711
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $191 |
| E.R. Squibb & Sons, L.L.C. | 12 | $139 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| Novo Nordisk Inc | 4 | $71 |
| Ceribell, Inc. | 3 | $57 |
| Mallinckrodt Hospital Products Inc. | 2 | $53 |
| SCPHARMACEUTICALS INC. | 2 | $35 |
| UCB, Inc. | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Amgen Inc. | 1 | $19 |
Products named: ELIQUIS, LEQVIO, POCKET EEG DEVICE, TERLIVAZ, Ozempic, CAMZYOS, FUROSCIX, Briviact.
Industry payments across MD — which companies pay providers there.
